Expression of EBAF in disease tissues of VSD patients was lower compared to healthy fetuses, and chromatin immunoprecipitation (ChIP) assays showed that HAT p300 is involved in the activation of EBAF through inducing hyperacetylation of histone H4 at the EBAF promoter [98]. Here, LEFTY2 is linked to ventricular septal defect.